Cell Line | Tumor Subtype | Age | Ethnicity | Gender | Source | Site |
---|---|---|---|---|---|---|
NCI-H146 | SCLC | 59 | Caucasian | M | metastasis | bone |
NCI-H187 | SCLC | 47 | Caucasian | M | metastasis | pleural |
NCI-H209 | SCLC | 55 | Caucasian | M | metastasis | bone |
NCI-H526 | SCLC | 55 | Caucasian | M | metastasis | bone |
NCI-H889 | SCLC | 69 | Caucasian | F | metastasis | lymph |
NCI-H1672 | SCLC | 58 | Caucasian | M | primary | lung |
NCI-H2107 | SCLC | 36 | Black | M | metastasis | bone |
NCI-H2171 | SCLC | 50 | Caucasian | M | metastasis | pleural |
NCI-H2195 | SCLC | 67 | Caucasian | M | metastasis | bone |
NCI-H157 | NSCLC (squamous) | 59 | Caucasian | M | metastasis | pleural |
NCI-H1819 | NSCLC (adenocarcinoma) | 55 | Caucasian | F | metastasis | lymph |
NCI-H2052 | NSCLC (mesothelioma) | 65 | Caucasian | M | metastasis | pleural |
NCI-H2887 | NSCLC (squamous) | 31 | unknown | M | primary | lung |
HCC366 | NSCLC (adenosquamous) | 80 | unknown | F | primary | lung |
HCC1195 | NSCLC (adenocarcinoma) | 47 | Black | M | primary | lung |
HCC2450 | NSCLC (squamous) | 52 | Caucasian | M | primary | lung |
HBEC2-KT | Immortalized Normal | 68 | Â | M | NA | lung |
HBEC3-KT | Immortalized Normal | 65 | Â | F | NA | lung |
HBEC4-KT | Immortalized Normal | 71 | Â | F | NA | lung |